Anita Kohli, MD

Arizona Liver Health

Disclosure(s): Eli Lilly: Received clinical trial revenue; Gilead Sciences, Inc.: Advisor/Consultant, Received clinical trial revenue; Vir: Received clinical trial revenue

Poster(s):

• (P-2036) Obeldesivir for Treatment of COVID-19 in Adults and Adolescents Without Risk Factors for Progression to Severe Disease: the OAKTREE Study
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT